Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M L Lever

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 12, 2011
Intracellular defenses against HIV, viral evasion and novel therapeutic approachesRobert A Lever, Andrew M L Lever
The Journal of General Virology|February 13, 2001
The rapamycin sensitivity of human T-cell leukaemia virus type I-induced T-cell proliferation is mediated independently of the polypyrimidine motifs in the 5' long terminal repeatNicola J Rose, Andrew M L Lever
Retrovirology|November 17, 2016
HIV and Zika: When will we be able to end these epidemics?Mark A Wainberg, Andrew M L Lever
Retrovirology|April 6, 2005
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interactionDavid J Grainger, Andrew M L Lever
Journal of Virology|October 17, 2006
Human immunodeficiency virus type 1 Gag polyprotein modulates its own translationEmma C Anderson, Andrew M L Lever
Trends in Microbiology|December 26, 2012
HIV Gag polyprotein: processing and early viral particle assemblyNeil M Bell, Andrew M L Lever
International Journal of Hematology|July 27, 2006
Replication of human immunodeficiency virus type 1 from entry to exitAndrew M L Lever, Kuan-Teh Jeang
British Medical Bulletin|May 10, 2011
XMRV, prostate cancer and chronic fatigue syndromeJulia C Kenyon, Andrew M L Lever
Retrovirology|April 5, 2007
Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-MybNicola J Rose, Andrew M L Lever
Viruses|December 14, 2011
The molecular biology of feline immunodeficiency virus (FIV)Julia C Kenyon, Andrew M L Lever
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 12, 2011
Intracellular defenses against HIV, viral evasion and novel therapeutic approachesRobert A Lever, Andrew M L Lever
The Journal of General Virology|February 13, 2001
The rapamycin sensitivity of human T-cell leukaemia virus type I-induced T-cell proliferation is mediated independently of the polypyrimidine motifs in the 5' long terminal repeatNicola J Rose, Andrew M L Lever
Retrovirology|November 17, 2016
HIV and Zika: When will we be able to end these epidemics?Mark A Wainberg, Andrew M L Lever
Retrovirology|April 6, 2005
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interactionDavid J Grainger, Andrew M L Lever
Journal of Virology|October 17, 2006
Human immunodeficiency virus type 1 Gag polyprotein modulates its own translationEmma C Anderson, Andrew M L Lever
Trends in Microbiology|December 26, 2012
HIV Gag polyprotein: processing and early viral particle assemblyNeil M Bell, Andrew M L Lever
International Journal of Hematology|July 27, 2006
Replication of human immunodeficiency virus type 1 from entry to exitAndrew M L Lever, Kuan-Teh Jeang
British Medical Bulletin|May 10, 2011
XMRV, prostate cancer and chronic fatigue syndromeJulia C Kenyon, Andrew M L Lever
Retrovirology|April 5, 2007
Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-MybNicola J Rose, Andrew M L Lever
Viruses|December 14, 2011
The molecular biology of feline immunodeficiency virus (FIV)Julia C Kenyon, Andrew M L Lever
Pageof 9